
Out-of-Pocket Costs for MS Drugs; Part 4 of the Thunderclap Headache Series
Neurology® Podcast
00:00
How Do We Fix This?
There's a lot of politically strong players involved that really prevent radical changes in the way we pay for pharmacutical is to occur. There'r several promising pieces of legislation that are under consideration right now. I think one of the more likely scenarios to play out of the next year intr of least medicare reform from the patient perspective would be some sort of out of pocket cap for patients in the park d program.
Transcript
Play full episode